Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/32702
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles
Peer Review Status: Refereed
Title: Rapid literature review on the impact of health messaging and product information on alcohol labelling
Author(s): Dimova, Elena D
Mitchell, Danielle
Keywords: Alcohol labelling
product information
health messaging
rapid review
Issue Date: 1-Jun-2021
Date Deposited: 11-Jun-2021
Citation: Dimova ED & Mitchell D (2021) Rapid literature review on the impact of health messaging and product information on alcohol labelling. Drugs: Education Prevention and Policy. https://doi.org/10.1080/09687637.2021.1932754
Abstract: Background and aim Alcohol labelling enables people to make informed decisions about the products they purchase and consume. This rapid review explores the impact of health messaging and product information on consumer attention, comprehension, recall, judgment and behavioural compliance in relation to alcohol use. Methods The rapid review adopted a multi-faceted search strategy to identify primary studies on health messaging and/or product information on alcohol packaging, and the impact of these on consumer-related outcomes. Results The review provides support for large, colourful labels on the front of alcohol products and the use of plain packaging to increase the visibility of health messaging. It also supports the use of explicit, negatively-framed statements that link alcohol to specific diseases. Colour-coded schemes and pictorial warnings may further optimize the effectiveness of alcohol labels. We did not find sufficient evidence to support the effectiveness of product information alone in influencing consumerattention, comprehension, recall, judgment and behavioural compliance. Conclusion Well-designed alcohol labels can positively influence consumers’ attention, comprehension, recall, judgment and behavioural compliance. The findings have implications for alcohol labelling research and policy.
DOI Link: 10.1080/09687637.2021.1932754
Rights: © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Notes: Output Status: Forthcoming/Available Online
Licence URL(s): http://creativecommons.org/licenses/by/4.0/

Files in This Item:
File Description SizeFormat 
Dimova-Mitchell-Drugs-2021.pdfFulltext - Published Version1.62 MBAdobe PDFView/Open



This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.